Skip to main content
. 2018 Oct 23;8:15658. doi: 10.1038/s41598-018-33927-5

Table 5.

Multivariate analysis of DFS and known prognostic factors in stage II-III colon carcinoma patients.

Parameters No. at riska Events HR 95% CI p value HR 95% CI p value
Sex 0.24 0.26
  Female 401 133 1.00 1.00
  Male 466 166 1.15 0.91–1.45 1.14 0.91–1.44
Age <0.0001* <0.0001*
  <65 387 103 1.00 1.00
  ≥65 480 195 1.64 1.29–2.08 1.68 1.32–2.13
pT stage 0.009 0.007
  T1-2 32 5 1.00 1.00
  T3-4 833 227 3.26 1.34–7.94 3.39 1.39–8.26
pN stage <0.0001* <0.0001*
  Negative 457 125 1.00 1.00
  Positive 410 173 1.83 1.45–2.31 1.90 1.50–2.40
Tumor location 0.04 0.06
  Proximal colon 425 157 1.00 1.00
  Distal colon 442 141 0.78 0.62–0.98 0.81 0.64–1.01
CD8+ TILs <0.0001
  High 283 60 1.00
  Low 584 238 1.86 1.40–2.49
Tumor CD274(PD-L1) 0.009
  High 384 108 1.00
  Low 480 190 1.37 1.08–1.74
CD8+ TILs and tumor CD274(PD-L1) <0.0001
  High or high 507 137 1.00
  Low/Low 360 161 1.77 1.41–2.22

aNumber of cases may differ due to missing data. *p < 0.005 is significant and 0.005 < p < 0.05 is suggestive evidence.